All Beta-Thalassemia
January 20, 2021
CRISPR technology to potentially cure sickle cell disease at UICUIC will be participating in clinical trials to cure severe red blood congenital diseases such as sickle cell anemia or Thalassemia by safely modifying the DNA of patients’ blood cells using CRISPR technology.